3180 results for «730»
3180 results
Valve in valve - TAV in TAV - Part 2
21 Nov 2023 – From PCR London Valves 2023
Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...
Treatment of paravalvular leak
21 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in paravalvular leak management with this selection of cases: discover the unique strategy of employing three plugs to close a challenging mitral paravalvular leak, navigate the challenges of tackling device migration and retrieval in the closure of a sizable aortic paravalvular leak, gain...
TAVI - Coronary complications
21 Nov 2023 – From PCR London Valves 2023
Explore challenging situations in this session: witness the rare occurrence of coronary embolization resulting from a fractured biological surgical valve in an aortic valve-in-valve procedure, uncover the complexities surrounding the late presentation of cardiogenic shock after TAVR, navigate the unusual challenge of intermittent left main obstruction caused...
Mitral valve interventions in challenging clinical situations
21 Nov 2023 – From PCR London Valves 2023
Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...
Aortic regurgitation - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Rare complications of structural intervention
21 Nov 2023 – From PCR London Valves 2023
Join us in this session for a look at rare and challenging scenarios in structural interventions: delve into the complexities of an ascending aorta mycotic aneurysm in a patient with a prior TAVI procedure, witness a unique case showcasing a misloaded self-expanding TAVR device, uncover the...
Prevention and treatment of left ventricular outflow tract obstruction
19 Nov 2023 – From PCR London Valves 2023
Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!
Transcatheter mitral repair and replacement for primary mitral regurgitation - LIVE case
19 Nov 2023 – From PCR London Valves 2023
This session aims to highlight the remarkable advancements achieved in transcatheter mitral valve intervention over the past two decades, since its inception. Follow two TEER cases which illustrate this rapidly growing field:
- Transcatheter edge-edge mitral valve repair
A 77-year-old male with a history of SAVR (bioprothesis) + LIM-LAD/Diag, normal...
Key questions in mitral valve intervention - What do I need to know about imaging?
19 Nov 2023 – From PCR London Valves 2023
Explore the crucial aspects of imaging in mitral valve intervention with a focus on the entire treatment pathway, from patient selection to post-procedural follow-up. Gain insights into optimizing patient selection for mitral valve edge-to-edge repair and replacement, and learn key views essential for optimal imaging and...
Contemporary approach in the treatment of calcified coronary artery disease
28 Feb 2026 – From Euro4C Annual Meeting 2026
Adopt a contemporary approach to managing calcified coronary artery disease by leveraging high-definition IVUS for lesion assessment and morphology evaluation. Learn to tailor calcium modification strategies based on IVUS findings and combine available tools to optimize treatment outcomes according to patient and lesion profiles.
TEER in complex tricuspid regurgitation - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
A 79-year-old male with permanent AF, prior colorectal and prostate cancer, and a Mosaic bioprosthetic mitral valve implanted in 2016, presented with torrential tricuspid regurgitation and preserved LV function.
Three G5 clips were implanted: two anteroseptal (1 XTW and 1 XT) and one posteroseptal XTW.
LIVE Educational Case...
Primary mitral TEER in small anatomy - LIVE case
15 Feb 2026 – From PCR Tokyo Valves 2026
An 89-year-old male with diabetes mellitus, hypertension, chronic kidney disease (eGFR: 46), and CAD with a history of NSTEMI and CTO of the RCA, presented with symptomatic primary mitral regurgitation (P1–P2 prolapse) and preserved LV function (56%).
One Pascal ACE device was implanted.
LIVE Educational Case from Nagoya...
Mitral and aortic transcatheter valve-in-valve intervention - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...
Femoral artery pseudoaneurysm expansion managed through subcutaneous fat embolization
06 Apr 2021
Femoral artery pseudoaneurysm is a known complication following cardiac catheterization. Rarely, expansion of the pseudoaneurysm can occur and is often catastrophic. We describe a unique method employed by our centre to deal with such a complication.
Author
PCR @ TCT 2024 - Get the international perspective!
27 Oct 2024
Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement
18 Sep 2022
Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
